Stock 2162 KEYMED BIOSCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Keymed Biosciences Inc.

Equities

2162

KYG5252B1023

Market Closed - Hong Kong S.E.
Other stock markets
 04:08:22 2024-04-29 EDT 		5-day change 1st Jan Change
33.5 HKD -4.01% Intraday chart for Keymed Biosciences Inc. +14.92% -31.77%
04-29 Keymed Biosciences Allergy Drug Achieves Phase III Clinical Trial End Points MT
04-28 Keymed Biosciences Inc. Announces Phase III Clinical Trial of Stapokibart Injection for the Treatment of Seasonal Allergic Rhinitis CI

Evolution of the average Target Price on Keymed Biosciences Inc.

Price target over the last 5 years

History of analyst recommendation changes

d796828e758.atM2vbgro1mG3jq2d306cNK86amtrJpYD6DUi7IsVqc.W-JFid1yygbv613_JChuAovoofDo2PMRNsWxpthIOcFfvGeL4VqQMOGRaw~81516f4318c3991b0e2cca969d4c55f5

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
10
Last Close Price
30.99 CNY
Average target price
54.52 CNY
Spread / Average Target
+75.95%
High Price Target
63.14 CNY
Spread / Highest target
+103.78%
Low Price Target
49.06 CNY
Spread / Lowest Target
+58.33%

Consensus detail

Consensus revision (last 18 months)

Ratings for Keymed Biosciences Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. 2162 Stock
  4. Consensus Keymed Biosciences Inc.